Europe API intermediates Market – Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Published Report
  • Apr 2021
  • Europe
  • 350 Pages
  • No of Tables: 149
  • No of Figures: 50

Europe API Intermediates Market, By Type (Veterinary Drug Intermediates Pharmaceutical / Bulk Drug Intermediates), Product (Bromo Compound, O-Benzyl Salbutamol, Hemisulfate, Oxirane, Bisoprolol Base, Chiral PCBHP, Pheniramine Base, Chlorpheniramine Base, Brompheniramine Base, Mepyramine/Pyrilamine Base, 6-Amino-1,3-Dimethyl Uracil, Theofylline, Acefylline, Xanthine, Nitriles, Others), Therapeutic Type (Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, Dermatology, Urology, Others), Customers (Direct Users/Pharma Companies, Traders/Wholesalers/Distributors, Associations/Govt. Institutions/Pvt Institutions), End User (API Manufacturer, Finished Product Manufacturer), Distribution Channel (Direct Tender, Retail Sales, Others), Country (Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe) Industry Trends & Forecast to 2028

Europe API intermediates Market

Market Analysis and Insights: Europe API intermediates Market

Europe API intermediates market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.1% in the forecast period of 2021 to 2028 and is expected to reach USD 10,594.65 million by 2028. High burden of chronic disorders and increase in aging population are the major drivers which propelled the demand of the market in the forecast period.

Active pharmaceutical ingredients are the substance or combination of substances intended to be used in the manufacturing of a drug product, which when used in the production of the drug, becomes an active pharmaceutical ingredient. Such substances are used to provide pharmacological activity. The final drug dosage form is formulated using the APIs and excipient but the APIs are formulated using the raw material which is known as intermediates. API intermediates are the kind of material that is produced in the process of API. The intermediates are the by-product of the active pharmaceutical ingredients and provide the same therapeutic activity as that of APIs. These intermediates are also used to cure different kinds of chronic diseases such as cancers, respiratory diseases, and infectious diseases among others.

API intermediates are the agents or compounds that are used as raw materials for the formulation or production of active pharmaceutical ingredients. These intermediates go under refinement or molecular changes to form a final API. Different technologies such as amination, alkoxylation, electrochemistry, hydrogenation, hydroformylation, acetylene chemistry, phosgene chemistry, and other technologies are involved in the production of intermediates.

The API intermediates market is growing with the increasing prevalence of various chronic disorders and the increasing aging population. Moreover, increasing research and development regarding pharmaceutical APIs and their intermediates are other factors accelerating the API intermediates market growth.

The API intermediates market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.

Europe API intermediates Market

Europe API Intermediates Market Scope and Market Size

The intermediates market is segmented on the based on the basis of type, product, therapeutic type, customers, end users, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, API intermediates market is segmented into veterinary drug intermediates pharmaceutical / bulk drug intermediates. In 2021, pharmaceutical / bulk drug intermediates is expected to dominate the API intermediates market due to rising demand of APIs for the production of finished goods and rising prevalence of various diseases which required continues production of drugs.
  • On the basis of product, API intermediates market is segmented into bromo compound, O-benzyl salbutamol, hemisulfate, oxirane, bisoprolol base, chiral PCBHP, pheniramine base, chlorpheniramine base, brompheniramine base, mepyramine/pyrilamine base, 6-amino-1,3-dimethyl uracil, theofylline, acefylline, xanthine, nitriles, and others. In 2021, nitriles segment is expected to dominate the API intermediates market due to the high cost of the products and continues research and development for the innovative APIs.
  • On the basis of therapeutic type, API intermediates market is segmented into autoimmune diseases, oncology, metabolic diseases, ophthalmology, cardiovascular diseases, infectious diseases, neurology, respiratory disorders, dermatology, urology, and others. In 2021, cardiovascular diseases segment is expected to dominate the API intermediates market because cardiovascular is the leading cause of death globally.
  • On the basis of customers, API intermediates market is segmented direct users/pharma companies, traders/wholesalers/distributors, and associations/govt. institutions/Pvt institutions. In 2021, direct users/pharma companies segment is expected to dominate the API intermediates market because APIs manufacture are the primary and direct user for the intermediates. Rising Contract manufacturing also boost the market.
  • On the basis of end user, API intermediates market is segmented into API manufacturer, and finished product manufacturer. In 2021, API manufacturer segment is dominating the API intermediates market because intermediates are the primary chemical substrate of the APIs, which can be further converted in APIs. So, the intermediates is widely used by the API manufacturer to reduce the cost of manufacturing.
  • On the basis of distribution channel, API intermediates market is segmented into direct tender, retail sales, and others. In 2021, direct tender is expected to dominate the API intermediates market because direct tender provides huge margin for the purchase good and direct tender has competitive selection of contract and consultants there is accountability.

API Intermediates Market Country Level Analysis

The API intermediates market is analyzed and market size information is provided on the basis of type, product, therapeutic type, customers, end users, and distribution channel as referenced above.

The countries covered in the Europe API intermediates market report are the Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe.

Germany is leading the growth of the Europe region and pharmaceutical/bulk drug intermediates segment is dominating in this country because Germany is the highest active pharmaceutical ingredient producer globally. The U.K is the fastest growing country due to rising government initiatives for the production of APIs.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Research and Development Regarding Pharmaceutical APIs and their intermediates and Increasing Disease Awareness and Education are boosting the Market Growth of API Intermediates

API intermediates market also provides you with detailed market analysis for every country growth in API intermediates industry with API intermediates drugs sales, impact of advancement in the API intermediates technology and changes in regulatory scenarios with their support for the API intermediates market. The data is available for historic period 2010 to 2019.

Competitive Landscape and API Intermediates Market Share Analysis

API intermediates market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to API intermediates market.

The major companies which are dealing in the API intermediates are HIKAL Ltd., Cambrex Corporation, Ganesh-Group, AlzChem Group AG, Vasudha Pharma, Anyang General Chemical Co.,Ltd., Sarex, Sandoo Pharmaceuticals and Chemicals Co., Ltd., Atul Ltd, Sandoz International GmbH  (a subsidiary of Novartis AG), Aceto, Supriya Lifescience Ltd., Vertellus, Dishman Carbogen Amcis Ltd, Sanofi, Divi's Laboratories Limited, AARTI INDUSTRIES LIMITED, Aurobindo Pharma, BASF SE among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the API intermediates market.

For instance,  

  • In January 2021, Vertellus has been acquired by the company, Pritzker Private Capital who partners with the middle-market companies established in North America and builds up the long-term relationship with that company. As Vertellus is considered as leading company or provider of specialty chemicals in different sectors such as healthcare, food & agriculture, personal care, transportation and coatings, so PPC has made a partnership with the company. This helped the company Vertellus to increase their market growth which will drive revenues of the company.
  • In November 2020, Cambrex Corporation had announced that the company will expand their API manufacturing capacity to meet the increasing demand from the consumer side. The company has invested USD 50.00 million to enhance their manufacturing capacity. The increase in API manufacturing will directly increase the production and requirement of intermediates which means that the company has to increase the manufacturing of both API and their intermediates. This expansion has helped the company to enhance their production in both the fields that is APIs and their intermediates which will increase the API intermediates market growth.

Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market player is enhancing the company market in the API intermediates market which also provides the benefit for organization to improve their offering for API intermediates.

Customization Available: Europe API intermediates Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS INTERMEDIATES: CUSTOMIZATION (COUNTRIES INVOLVED IN IMPORT & EXPORT)

TABLE 2 PERCENTAGE BREAK UP OF COST

TABLE 3 TENTATIVE LAND REQUIREMENT

TABLE 4 PERCENTAGE BREAK UP OF PLANT AREA

TABLE 5 TABLE: 1 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS INTERMEDIATES: LIST OF API OR FORMULATION COMPANIES WITH API INTERMEDIATE

TABLE 6 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC

TABLE 7 MARKET PLAYERS OF API INTERMEDIATES

TABLE 8 SALES DATA OF API INTERMEDIATES FOR 2019/2020

TABLE 9 EUROPE API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 10 EUROPE PHARMACEUTICAL INTERMEDIATES/ BULK DRUG INTERMEDIATES IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 EUROPE VETERINARY DRUG INTERMEDIATES IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 EUROPE API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 13 EUROPE NITRILES IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 EUROPE BROMO COMPOUND IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 EUROPE CHIRAL PCBHP IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 EUROPE CHLORPHENIRAMINE BASE IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 EUROPE BROMPHENIRAMINE BASE IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 EUROPE PHENIRAMINE BASE IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 EUROPE O-BENZYL SALBUTAMOL IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 EUROPE BISOPROLOL BASE IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 EUROPE HEMISULFATE IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 EUROPE OXIRANE IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 EUROPE MEPYRAMINE/PYRILAMINE BASE IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 EUROPE THEOFYLLINE IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 EUROPE ACEFYLLINE IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 EUROPE XANTHINE IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 EUROPE 6-AMINO-1, 3-DIMETHYL URACIL IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 EUROPE OTHERS IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 EUROPE API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 30 EUROPE CARDIOVASCULAR DISEASES IN API INTERMEDIATES MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 31 EUROPE METABOLIC DISEASES IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 EUROPEINFECTIOUS DISEASES IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 33 EUROPE RESPIRATORY DISEASES IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 34 EUROPE NEUROLOGY IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 35 EUROPE ONCOLOGY IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 36 EUROPE AUTOIMMUNE DISEASES IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 37 EUROPE DERMATOLOGY IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 38 EUROPE OPHTHALMOLOGY IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 39 EUROPE UROLOGY IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 40 EUROPE OTHERS IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 41 EUROPE API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 42 EUROPE DIRECT USERS/PHARMA COMPANIES IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 43 EUROPE TRADERS/WHOLESALERS/DISTRIBUTORS IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 44 EUROPE ASSOCIATIONS/GOVT. INSTITUTIONS/PVT INSTITUTIONSIN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 45 EUROPE API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 46 EUROPE API MANUFACTURER IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 47 EUROPE FINISHED PRODUCT MANUFACTURER IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 48 EUROPE API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 49 EUROPE DIRECT TENDER IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 50 EUROPE RETAIL SALES IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 51 EUROPE OTHERSIN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 52 EUROPE API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 53 EUROPE API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 54 EUROPE API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 55 EUROPE API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 56 EUROPE API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 57 EUROPE API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 58 EUROPE API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 59 GERMANY API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 60 GERMANY API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 61 GERMANY API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 62 GERMANY API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 63 GERMANY API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 64 GERMANY API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 65 U.K API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 66 U.K API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 67 U.K API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 68 U.K API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 69 U.K API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 70 U.K API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 71 U.K API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 72 ITALY API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 73 ITALY API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 74 ITALY API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 75 ITALY API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 76 ITALY API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 77 SPAIN API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 78 SPAIN API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 79 SPAIN API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 80 SPAIN API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 81 SPAIN API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 82 SPAIN API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 83 FRANCE API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 84 FRANCE API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 85 FRANCE API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 86 FRANCE API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 87 FRANCE API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 88 FRANCE API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 89 NETHERLANDS API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 90 NETHERLANDS API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 91 NETHERLANDS API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 92 NETHERLANDS API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 93 NETHERLANDS API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 94 NETHERLANDS API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 95 RUSSIA API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 96 RUSSIA API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 97 RUSSIA API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 98 RUSSIA API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 99 RUSSIA API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 100 RUSSIA API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 101 SWITZERLAND API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 102 SWITZERLAND API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 103 SWITZERLAND API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 104 SWITZERLAND API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 105 SWITZERLAND API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 106 SWITZERLAND API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 107 TURKEY API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 108 TURKEY API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 109 TURKEY API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 110 TURKEY API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 111 TURKEY API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 112 TURKEY API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 113 AUSTRIA API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 114 AUSTRIA API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 115 AUSTRIA API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 116 AUSTRIA API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 117 AUSTRIA API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 118 AUSTRIA API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 119 NORWAY API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 120 NORWAY API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 121 NORWAY API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 122 NORWAY API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 123 NORWAY API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 124 NORWAY API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 125 HUNGARY API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 126 HUNGARY API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 127 HUNGARY API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 128 HUNGARY API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 129 HUNGARY API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 130 HUNGARY API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 131 LITHUANIA API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 132 LITHUANIA API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 133 LITHUANIA API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 134 LITHUANIA API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 135 LITHUANIA API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 136 LITHUANIA API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 137 IRELAND API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 138 IRELAND API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 139 IRELAND API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 140 IRELAND API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 141 IRELAND API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 142 IRELAND API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 143 POLAND API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 144 POLAND API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 145 POLAND API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 146 POLAND API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 147 POLAND API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 148 POLAND API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 149 REST OF ASIA PACIFIC API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions